Lindo Medical Care LLC is categorized under Blood Related Health Services in Brooksville, FL and active since 2007.
Lindo Medical Care LLC was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Oscar Lindo, Owner at the company’s single location by writing to 10045 Cortez Boulevard # 154, Brooksville, Florida FL 34613 or by phoning (352) 596-6114. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Lindo Medical Care LLC |
Contact Person: | Oscar Lindo, Owner |
Address: | 10045 Cortez Boulevard # 154, Brooksville, Florida 34613 |
Phone Number: | (352) 596-6114 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Blood Related Health Services |
SIC Code: | 8099 |
NAICS Code: | 6214930 |
Share This Business: |
Lindo Medical Care LLC was started in 2007 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Oscar Lindo, Owner for inquiries that concern Lindo Medical Care LLC by calling the company number (352) 596-6114, as your correspondence is most welcome. Additionally, the physical location of the single location of Lindo Medical Care LLC can be found at the coordinates 28.52422,-82.55832 as well as the street address 10045 Cortez Boulevard # 154 in Brooksville, Florida 34613.
For its online presence, you may visit Lindo Medical Care LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.